Here are the latest quarterly results of GLENMARK PHARMA. For more details, see the GLENMARK PHARMA financial fact sheet and GLENMARK PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 30,191 | 27,773 | 33,752 | 31,002 | 33,737 | 34,016 | 32,074 | 25,067 | |
Other income | Rs m | 1,072 | 1,832 | 974 | 706 | -402 | 209 | 17 | 454 | |
Turnover | Rs m | 31,263 | 29,604 | 34,727 | 31,707 | 33,335 | 34,225 | 32,091 | 25,521 | |
Expenses | Rs m | 25,557 | 23,457 | 27,537 | 26,261 | 27,687 | 27,704 | 27,451 | 27,154 | |
Gross profit | Rs m | 3,809 | 4,316 | 6,216 | 5,079 | -1,948 | 5,792 | 1,369 | -2,854 | |
Depreciation | Rs m | 1,315 | 1,468 | 1,557 | 1,515 | 1,465 | 1,547 | 1,415 | 1,471 | |
Interest | Rs m | 869 | 600 | 831 | 971 | 1,093 | 1,120 | 1,215 | 1,343 | |
Profit before tax | Rs m | 2,697 | 4,080 | 4,802 | 3,299 | -4,908 | 3,334 | -1,244 | -5,214 | |
Tax | Rs m | 971 | 1,969 | 2,015 | 1,441 | -876 | 1,603 | 559 | -718 | |
Profit after tax | Rs m | 1,726 | 2,111 | 2,787 | 1,858 | -4,031 | 1,731 | -1,803 | -4,496 | |
Gross profit margin | % | 12.6 | 15.5 | 18.4 | 16.4 | -5.8 | 17.0 | 4.3 | -11.4 | |
Effective tax rate | % | 36.0 | 48.3 | 42.0 | 43.7 | 17.9 | 48.1 | -45.0 | 13.8 | |
Net profit margin | % | 5.7 | 7.6 | 8.3 | 6.0 | -11.9 | 5.1 | -5.6 | -17.9 | |
Diluted EPS | Rs | 6.1 | 7.5 | 9.9 | 6.6 | -14.3 | 6.1 | -6.4 | -15.9 | |
Diluted EPS (TTM) | Rs | 35.2 | 31.8 | 32.0 | 30.1 | 9.7 | 8.3 | -8.0 | -30.5 | |
Subscriber Feature |
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.